PS3-6: Blood Safety Continuous Active-Surveillance Network Feasibility Evaluation (Blood-SCAN)
| Autor: | Craig Zinderman, Madhavi Vajani, Meghan A Baker, Crystal Garcia, Jillian E. Lauer, Elizabeth A. Chrischilles, Jerald Mullersman, Michael Nguyen, Cynthia Nakasato, Karen Riedlinger, Carolyn Balsbaugh |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2013 |
| Předmět: |
Community and Home Care
Safety surveillance Pathology medicine.medical_specialty Distributed database business.industry Blood component General Medicine Health outcomes medicine.disease Food and drug administration Medicine Blood safety Medical emergency business Selected Abstracts-HMORN 2013: Pharmacoepidemiology |
| Popis: | Background/Aims In 2011, the US Food and Drug Administration (FDA) created the Blood Safety Continuous Active-Surveillance Network (Blood-SCAN), the first nationwide active surveillance system for monitoring the safety of FDA-regulated blood components and blood-derived products. Blood-SCAN employs the Mini-Sentinel Distributed Database (MSDD) which contains 126 million individuals within 17 Data Partners. Blood-SCAN is intended to augment the existing safety surveillance system and improve US biovigilance efforts. As a first step in creating Blood-SCAN, we assessed the feasibility of using the current MSDD to evaluate blood component and blood-derived product exposures and related health outcomes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|